Skip to main content Skip to section navigation Skip to footer
Investors & Media Clinical Trials Careers Contact Us
Facebook link Twitter link Linkedin link
CymaBay Therapeutics
  • Home
  • Our Company
    • Overview
    • Leadership Team
    • Board of Directors
  • Our Purpose
    • Overview
    • About Liver Disease
    • About PBC
    • Patient Advocacy
    • Patient Resources
    • Grants & Giving
    • Expanded Access
  • Our Science
    • Overview
    • Unmet Needs in PBC
    • Seladelpar
    • MBX-2982
    • Collaborations
  • Investors & Media
  • Clinical Trials
  • Careers
  • Contact Us

IR Calendar

Investors & Media

Investors & Media

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Presentations
    • Publications
    • Email Alerts
  • Company Info
    • Overview
    • Leadership Team
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents

  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Presentations
  • Publications
  • Email Alerts

First Quarter 2023 Financial Results Conference Call

May 15, 2023 4:30 pm EDT
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP
  • Email Alerts
  • Company Profile
  • Contacts
  • RSS News Feed
©2023 CymaBay Therapeutics. All Rights Reserved.
Privacy Policy Disclaimer Sitemap Manage Cookie Preferences
Facebook link Twitter link Linkedin link

You are leaving our website!

Continue